메뉴 건너뛰기




Volumn 112, Issue 4, 2010, Pages 1056-1057

Erroneously published fospropofol pharmacokinetic-pharmacodynamic data and retraction of the affected publications

Author keywords

[No Author keywords available]

Indexed keywords

FOSPROPOFOL;

EID: 77950847854     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181d536df     Document Type: Letter
Times cited : (14)

References (9)
  • 1
    • 56149112724 scopus 로고    scopus 로고
    • Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation (letter)
    • reply
    • Shah A, Mistry B, Gibiansky E, Gibiansky L: Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation (letter). ANESTHESIOLOGY 2008; 109:937; reply
    • (2008) ANESTHESIOLOGY , vol.109 , pp. 937
    • Shah, A.1    Mistry, B.2    Gibiansky, E.3    Gibiansky, L.4
  • 2
    • 58749111302 scopus 로고    scopus 로고
    • Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation
    • Shah A, Mistry B, Gibiansky E, Gibiansky L: Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation. Anesth Analg 2009; 108:382
    • (2009) Anesth Analg , vol.108 , pp. 382
    • Shah, A.1    Mistry, B.2    Gibiansky, E.3    Gibiansky, L.4
  • 3
    • 64849103977 scopus 로고    scopus 로고
    • Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation
    • Shah A, Mistry B, Gibiansky E, Gibiansky L: Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation. Eur J Anaesthesiol 2009; 26:81
    • (2009) Eur J Anaesthesiol , vol.26 , pp. 81
    • Shah, A.1    Mistry, B.2    Gibiansky, E.3    Gibiansky, L.4
  • 4
    • 0041343200 scopus 로고    scopus 로고
    • Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers
    • DOI 10.1097/00000542-200308000-00012
    • Fechner J, Ihmsen H, Hatterscheid D, Schiessl C, Vornov JJ, Burak E, Schwilden H, Scḧuttler J: Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers. ANESTHESIOLOGY 2003; 99:303-313 (Pubitemid 36909556)
    • (2003) Anesthesiology , vol.99 , Issue.2 , pp. 303-313
    • Fechner, J.1    Ihmsen, H.2    Hatterscheid, D.3    Schiessl, C.4    Vornov, J.J.5    Burak, E.6    Schwilden, H.7    Schuttler, J.8
  • 7
    • 26244438839 scopus 로고    scopus 로고
    • AQUAVAN injection, a watersoluble prodrug of propofol, as a bolus injection: A phase i dose-escalation comparison with DIPRIVAN (part 1): Pharmacokinetics
    • Gibiansky E, Struys MM, Gibiansky L, Vanluchene AL, Vornov J, Mortier EP, Burak E, Van Bortel L: AQUAVAN injection, a watersoluble prodrug of propofol, as a bolus injection: A phase I dose-escalation comparison with DIPRIVAN (part 1): Pharmacokinetics. ANESTHESIOLOGY 2005; 103:718-729
    • (2005) ANESTHESIOLOGY , vol.103 , pp. 718-729
    • Gibiansky, E.1    Struys, M.M.2    Gibiansky, L.3    Vanluchene, A.L.4    Vornov, J.5    Mortier, E.P.6    Burak, E.7    Van Bortel, L.8
  • 8
    • 26244464421 scopus 로고    scopus 로고
    • AQUAVAN injection, a watersoluble prodrug of propofol, as a bolus injection: A phase i dose-escalation comparison with DIPRIVAN (part 2): Pharmacodynamics and safety
    • Struys MM, Vanluchene AL, Gibiansky E, Gibiansky L, Vornov J, Mortier EP, Van Bortel L: AQUAVAN injection, a watersoluble prodrug of propofol, as a bolus injection: A phase I dose-escalation comparison with DIPRIVAN (part 2): Pharmacodynamics and safety. ANESTHESIOLOGY 2005; 103:730-743
    • (2005) ANESTHESIOLOGY , vol.103 , pp. 730-743
    • Struys, M.M.1    Vanluchene, A.L.2    Gibiansky, E.3    Gibiansky, L.4    Vornov, J.5    Mortier, E.P.6    Van Bortel, L.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.